LPCN Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting
Lipocine Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.25
+2.7% in 3d after detection
Post-detection moves
1h
—
1d
+1.8%
3d
+2.7%
7d
+2.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS